Early research (Phase 1)Study completedNCT02983006What this trial is testingStudy of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 12
Large-scale testing (Phase 3)Ended earlyNCT02967692What this trial is testingThe Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 568
Not applicableStudy completedNCT04040114What this trial is testingImproving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI)Who this might be right forSkin CancerMelanoma (Skin) Melanoma and Skin Cancer Trials Limited 200
Large-scale testing (Phase 3)Study completedNCT04889118What this trial is testingSafety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension StudyWho this might be right forMalignant Melanoma Merck Sharp & Dohme LLC 131
Not applicableStudy completedNCT04728113What this trial is testingEarly Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)Who this might be right forUveal Melanoma Institut Curie 162
Testing effectiveness (Phase 2)Study completedNCT00577382What this trial is testingSU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous MelanomaWho this might be right forMucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma Dana-Farber Cancer Institute 52
Not applicableStudy completedNCT02854124What this trial is testingTracing Dissemination of Melanoma Cells in Healthy TissuesWho this might be right forMelanoma Assistance Publique - Hôpitaux de Paris 226
Early research (Phase 1)Active Not RecruitingNCT04044859What this trial is testingADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)Who this might be right forEndometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more USWM CT, LLC 120
Testing effectiveness (Phase 2)Looking for participantsNCT04787042What this trial is testingPhase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067Who this might be right forCancerSolid TumorMelanoma+6 more Simcha IL-18, Inc. 316
Early research (Phase 1)Not Yet RecruitingNCT07628894What this trial is testingCircadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte TherapyWho this might be right forAdvanced Cutaneous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more City of Hope Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00002669What this trial is testingCombination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 90
Not applicableStudy completedNCT07651020What this trial is testingThe Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsWho this might be right forPancreatic CancerBreast CancerLung Cancer+6 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
Not applicableUnknownNCT01680562What this trial is testingIn-vivo Optical Coherence Tomography Imaging in DermatooncologyWho this might be right forNon-melanocytic Skin TumorsMelanocytic Skin Tumors Medical University of Vienna 37
Not applicableWithdrawnNCT04099446What this trial is testingA Non-Interventional Pilot Study to Explore the Skin Microbes in Skin CancerWho this might be right forSkin CancerMelanoma (Skin)Squamous Cell Carcinoma+2 more ProgenaBiome
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207086What this trial is testingA Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III MelanomaWho this might be right forMelanoma Stage III Melanoma Institute Australia 21
Large-scale testing (Phase 3)Looking for participantsNCT07804186What this trial is testingStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal MelanomaWho this might be right forUveal Melanoma IDEAYA Biosciences 450
Not applicableActive Not RecruitingNCT04565769What this trial is testingCognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint InhibitorsWho this might be right forMelanomaCognitive ImpairmentFatigue+6 more Aarhus University Hospital 100
Early research (Phase 1)Active Not RecruitingNCT06781983What this trial is testingSafety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Innate Pharma 145
Early research (Phase 1)Ended earlyNCT05388877What this trial is testingE6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic MelanomaWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Central Nervous System+1 more Mayo Clinic 13
Post-approval studies (Phase 4)WithdrawnNCT02000739What this trial is testingGenetically-informed Therapies for Patients With Metastatic CancerWho this might be right forMetastatic Cancer Dartmouth-Hitchcock Medical Center